XBIO Shares Outstanding History
Below is a table of the XBIO shares outstanding history going back to 6/1/2016:

Date XBIO Shares Outstanding
6/1/2016778822
8/15/2016752073
11/7/2016690720
11/14/2016690720
3/30/2017721045
4/25/2017724795
5/11/2017726462
8/11/2017726462
11/13/2017726462
3/16/2018726462
4/26/2018726462
5/11/2018726462
8/6/2018783657
11/5/2018783657
3/15/2019870324
4/26/2019870324
5/6/2019870324
6/25/2019870324
8/9/20193.74M
8/1/2019200.20M
11/8/20195.76M
3/6/20206.28M
4/24/20206.28M
5/8/20206.28M
8/7/20206.30M
11/9/20206.30M
3/11/20218.75M
4/23/20218.75M
5/7/20218.75M
8/6/20219.70M
11/5/202113.39M
3/18/202213.44M
4/21/202213.44M
5/6/202214.32M

Also see: XBIO Market Cap History
XBIO YTD Return
XBIO Historical Shares Outstanding:
+63.37% CAGR
XBIO Historical Shares Outstanding: +63.37% CAGR

Mouse over chart for data details
6/1/2016 ...5/6/2022
Xenetic Biosciences is a biopharmaceutical company. Co.'s drug candidates pipeline include: XCART, which is a CAR T cell platform technology engineered to target patient-specific tumor neoantigens; ErepoXen (polysialylated erythropoietin), which uses Co.'s PolyXen platform technology for the treatment of anemia in chronic kidney disease patients; XBIO-101, which is an internal candidate with orphan drug designation from the U.S. Food and Drug Administration for the potential treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy; and OncoHist, which utilizes the properties of modified human histone H1.3 for targeted cell killing. We show 34 historical shares outstanding datapoints in our coverage of XBIO's shares outstanding history.

Understanding the changing numbers of XBIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like XBIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching XBIO by allowing them to research XBIO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree XBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Xenetic Biosciences (XBIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

XCUR Shares Outstanding History
XENT Shares Outstanding History
XERS Shares Outstanding History
XFOR Shares Outstanding History
XGN Shares Outstanding History
XLRN Shares Outstanding History
XNCR Shares Outstanding History
XOMA Shares Outstanding History
XON Shares Outstanding History
XRAY Shares Outstanding History
More Healthcare companies »

 

XBIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.